Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis
Top Cited Papers
- 19 September 2019
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 134 (21), 1783-1786
- https://doi.org/10.1182/blood.2019002289
Abstract
Emapalumab is a fully human IgG1 monoclonal antibody directed against interferon-gamma (IFN-ᵯE;), which in November 2018 received the first global approval for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent, or progressive disease or intolerance to HLH therapy. This review will highlight the pathophysiology of primary HLH, the therapeutic rationale for use of interferon-ᵯE; targeting therapy and potential limitations to its broader use in the treatment of HLH.Keywords
This publication has 22 references indexed in Scilit:
- Emapalumab: First Global ApprovalDrugs, 2019
- Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesPublished by American Society of Hematology ,2016
- Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosisHematology-American Society Hematology Education Program, 2015
- Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disordersCytokine & Growth Factor Reviews, 2015
- Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System FunctioningFrontiers in Immunology, 2014
- Adult haemophagocytic syndromeThe Lancet, 2014
- Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocolBlood, 2011
- Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functionsBlood, 2005
- Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantationBlood, 2002
- Perforin Gene Defects in Familial Hemophagocytic LymphohistiocytosisScience, 1999